Liquid Biopsy Market Projected to Reach 1.66 Billion USD by 2021

1
MarketsandMarkets Presents
Liquid Biopsy Market worth 1.66 Billion USD by
2021
http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
2
The report "Liquid Biopsy Market Cancer Type
(Lung, Breast, Colorectal, Prostate, Liver),
Circulating Biomarkers (Circulating Tumor Cells,
Circulating Tumor DNA), Product (Instruments,
Software), End User (Reference Laboratory,
Research Centers) - Forecast to 2021", provides a
detailed overview of the major drivers,
restraints, challenges, opportunities, current
market trends, and strategies impacting the
liquid biopsy market along with the estimates and
forecasts of the revenue. Browse 75 market data
Tables and 74 Figures spread through 160 Pages
and in-depth TOC on "Liquid Biopsy Market Cancer
Type (Lung, Breast, Colorectal, Prostate, Liver),
Circulating Biomarkers (Circulating Tumor Cells,
Circulating Tumor DNA), Product (Instruments,
Software), End User (Reference Laboratory,
Research Centers) - Forecast to
2021" http//www.marketsandmarkets.com/Market-Rep
orts/liquid-biopsy-market-13966350.html
 
http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
3
Early buyers will receive 10 customization on
this report.

 
http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
4

• The liquid biopsy market is expected to reach USD
  1.66 Billion by 2021 from USD 0.58 Billion in
  2016, growing at a CAGR of 23.4 during this
  period.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
5

• A number of factors, such as the rising
  incidence of cancer, benefits of liquid biopsy
  over solid tumor biopsy, technological
  advancements, availability of funding, and
  growing awareness about liquid biopsy through
  conferences and government initiatives, are
  driving the growth of the liquid biopsy market.
  However, unclear regulatory and reimbursement
  scenario is the major area of concern in this
  market.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
6

• In this report, the liquid biopsy market is
  segmented on the basis of cancer type,
  circulating biomarkers, products services, end
  users, and regions. Based on cancer type, the
  market is segmented into lung cancer, breast
  cancer, colorectal cancer, prostate cancer, liver
  cancer, and other cancers. The other cancers
  segment includes melanoma, bladder cancer, and
  ovarian cancer. In 2016, the lung cancer segment
  is expected to account for the largest share of
  the liquid biopsy market, followed by breast
  cancer.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
7

• Based on circulating biomarkers, the liquid
  biopsy market is categorized into four major
  segments, namely, circulating tumor cells (CTCs),
  circulating tumor DNA (ctDNA), Extracellular
  Vesicles (EVs), and other biomarkers. The other
  biomarkers segment includes circulating RNA and
  proteins. The circulating tumor cells segment is
  expected to account for the largest share of the
  global liquid biopsy market in 2016, followed by
  the circulating tumor DNA segment. Based on
  products and services, the liquid biopsy market
  is segmented into instruments, reagents, and
  services and software.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
8

• Based on end user, the liquid biopsy market is
  segmented into reference laboratories,
  hospital/physician laboratories, academic and
  research centers, and other end users. The other
  end-users segment includes public health
  laboratories, pathology laboratories, and small
  molecular laboratories.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
9

• In 2016, North America is expected to account for
  the largest share of the global liquid biopsy
  market. The large share of this regional segment
  can be attributed to factors such as easy
  accessibility and high adoption of advanced
  diagnostic technologies, such as PCR and NGS,
  among healthcare professionals increasing
  prevalence of cancer in the U.S. and Canada and
  continuous technological advancements in liquid
  biopsy. The Asia-Pacific liquid biopsy market,
  however, is estimated to witness the highest
  growth during the forecast period owing to the
  increasing focus of market players on this
  region.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
10

• Biocept Inc. (U.S.), Myriad Genetics (U.S.),
  QIAGEN (Netherlands), Roche (Switzerland),
  Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc.
  (U.S.), Guardant Health, Inc. (U.S.), Janssen
  Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft
  (Germany), and MDxHealth SA (U.S.) are the major
  players in the liquid biopsy market.

http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
11
Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html
12
About MarketsandMarkets
MarketsandMarkets is the global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. MMs flagship competitive intelligence
and market research platform, "RT" connects over
200,000 markets and entire value chains for
deeper understanding of the unmet insights along
with market sizing and forecasts of niche
markets. The new included chapters on Methodology
and Benchmarking presented with high quality
analytical infographics in our reports gives
complete visibility of how the numbers have been
arrived and defend the accuracy of the
numbers. We at MarketsandMarkets are inspired
to help our clients grow by providing apt
business insight with our huge market
intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/li
quid-biopsy-market-13966350.html